Finoriq research workspace
DEXCOM INC (DXCM) Insider Transactions & Form 4 Activity
Track insider acquisitions, dispositions, options, RSUs, and Form 4 activity for DEXCOM INC (DXCM).
Company Snapshot
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
- Company
- DEXCOM INC (DXCM)
- Ticker
- DXCM
- Market Cap
- $29.3B
- Latest Price
- $75.88
- Industry
- Medical Devices
DEXCOM INC (DXCM) Recent Insider Transactions
Recent market insider transaction records indexed for DEXCOM INC (DXCM).
| Insider | Code | Value | Transaction Date |
|---|---|---|---|
| Brown Michael JonEVP, Chief Legal Officer | S | Disposed | -$107,168 | 2026-04-15 |
| Brown Michael JonEVP, Chief Legal Officer | S | Disposed | -$110,245 | 2026-03-16 |
| Heller Bridgette PCommon Stock | S | Disposed | -$68,826 | 2026-02-12 |
| Collins Richard AlexanderCommon Stock | S | Disposed | -$171,599 | 2025-11-14 |
| Heller Bridgette PCommon Stock | S | Disposed | -$58,767 | 2025-11-12 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.